Disclaimer: This article was published in 2020 and reflects the information available at that time.
PREDNISOLONE Prednisolone is overrepresented in incident reports to PDL for a variety of reasons. Errors often occur when the 5 mg and 25 mg strengths are mixed up, which can result in under treatment or overdose. The dose printed on labels can also be involved in the error. For example, Prednisolone 25 mg daily for 3 days has been labelled as Prednisolone 25 mg three times daily for 3 days. High dose prednisolone intended only as a short course has been dispensed long term. This has resulted in numerous adverse effects such as osteoporosis, Cushing’s syndrome, weight gain and in…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Professional Indemnity Insurance – what hospital pharmacists need to know
1 April 2026
National
Learn more
Staying vaccination-ready
26 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
What pharmacists need to know about the new intranasal flu vaccine (FluMist®)
4 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more

It's time to renew your PDL membership for the year ahead.

Renew your PDL membership now and take a moment to review your Practice Profile, as updates have been made to our areas of practice. You can log in to the member portal using your email address or mobile number.